240
Participants
Start Date
September 29, 2017
Primary Completion Date
April 22, 2024
Study Completion Date
September 30, 2025
Human Acellular Vessel (HAV)
Surgical implantation of the HAV and subsequent use of the implanted vascular conduit for hemodialysis vascular access.
Arteriovenous fistula (AVF)
Surgical creation of an autologous arteriovenous fistula and subsequent use of the implanted vascular conduit for hemodialysis vascular access.
Hemodialysis
Procedure that filters a person's blood when their kidneys are no longer functioning properly
VA Pittsburgh, Pittsburgh
Surgical Specialists of Charlotte, Charlotte
The Regional Medical Center, Orangeburg
Grady Memorial Hospital, Atlanta
Coastal Vascular & Interventional, PLLC, Pensacola
Memorial Healthcare System, Pembroke Pines
Tampa General Hospital, Tampa
University of Tennessee Knoxville, Knoxville
United Surgical Associates, Lexington
Decatur Memorial Hospital, Decatur
South Plains Surgery Center, Lubbock
Denver Health Medical Center, Denver
Arizona Kidney Disease and Hypertension Center (AKDHC), Phoenix
University of Arizona, Tucson
University of Southern California, Los Angeles
VA Long Beach Healthcare System, Long Beach
Huntington Hospital, Pasadena
Olive View- UCLA Medical Center, Sylmar
University of California San Diego, Jacobs Medical Center, La Jolla
Balboa Nephrology, San Diego
University of CA, San Diego - LaJolla VA Hospital, La Jolla
Alliance Research, Laguna Hills
University of California, Irvine, Irvine
Mills Peninsula Hospital, San Mateo
UC Davis, Sacramento
Kaiser Permanente Sunnsyide, Portland
The Vascular Experts, Darien
Brigham and Women's Hospital, Boston
Kidney Care & Transplant Services of New England, West Springfield
Rutgers University, Newark
Overlook Medical Center, Summit
Lead Sponsor
Collaborators (1)
CTI Clinical Trial and Consulting Services
OTHER
California Institute for Regenerative Medicine (CIRM)
OTHER
Humacyte, Inc.
INDUSTRY